Breast cancer is classified into four types: luminal A, luminal B, human epidermal growth factor receptor-2 (HER-2) positive, and triple-negative breast cancer (TNBC); approximately 15% of breast cancer patients have TNBC [2]. Here, ERBB2 is linked to triple-negative breast carcinoma.